Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabriele Calvanese
Observed name:
G. Calvanese
Institutions:
University of Milan,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
University of Milan,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0009-0001-5758-5586
Observed ORCID:
0009-0001-5758-5586
OpenAlex ID:
A5002495340
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
2023
·
Giorgio Patelli
, Gianluca Mauri
, et al.
·
Clinical Cancer Research
·
45
PDF
The emerging role of PARP inhibitors in prostate cancer: A narrative review
2025
·
Lorenzo Lobianco
, Gabriele Calvanese
, et al.
·
Cancer Treatment Reviews
·
16
PDF
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective
2025
·
Anna Passarelli
, Sabrina Chiara Cecere
, et al.
·
Frontiers in Immunology
·
10
PDF
KELIM score: A marker of chemosensitivity in ovarian cancer
2025
·
Federica Adele Ambrosino
, Carmela Pisano
, et al.
·
Cancer Treatment Reviews
·
6
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study
2025
·
A. Sartore-Bianchi
, F. Toscano
, et al.
·
ESMO Gastrointestinal Oncology
·
2
PDF
72P Molecular characterization of advanced primary cardiac sarcomas
2023
·
A.G. Agostara
, G. Patelli
, et al.
·
ESMO Open
·
1
112P Clinicopathological characterization of MTAP-altered metastatic gastrointestinal tumors
2022
·
G. Mauri
, G. Patelli
, et al.
·
Annals of Oncology
·
1
PDF
Tumor Longevity: a time-dependent biomarker of immune checkpoint inhibitor responsiveness across head and neck, lung, renal and urothelial cancers
2026
·
Rebecca Romanò
, Chiara Airoldi
, et al.
·
The Oncologist
PDF
Current management and investigational therapeutic strategies in penile squamous cell carcinoma: A narrative review
2026
·
Lorenzo Lobianco
, Gabriele Calvanese
, et al.
·
Critical Reviews in Oncology/Hematology
PDF
Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a multicenter analysis from the Campania Oncological Network (ROC)
2026
·
Rosa Tambaro
, Gabriele Calvanese
, et al.
·
BMC Cancer
Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network
2026
·
Marilena Di Napoli
, Elisabetta Coppola
, et al.
·
Current Oncology
Cancer in migrant populations: evidence from a regional oncology network
2026
·
Elisabetta Coppola
, Chiara D’Alessio
, et al.
·
BMC Public Health
Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: A multicenter analysis from the Campania oncological network
2025
·
E. Perri
, R. Tambaro
, et al.
·
European Urology Open Science
Renal cell carcinoma in kidney transplant recipients receiving immunosuppression: A 55-year retrospective single-center study.
2025
·
Annalisa Zeppellini
, Giorgio Patelli
, et al.
·
Journal of Clinical Oncology
PDF
Association between site of metastases and survival stratification of the IMDC classification in metastatic renal cell carcinoma (mRCC).
2025
·
Annalisa Zeppellini
, Giorgio Patelli
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
15
Citation count:
81
H-index:
4
I10-index:
3
Year
Topic
Type